The kinetics of internalization, sequestration and metabolic degradation of atrial natriuretic factor (ANF)-receptor complex were studied in rat thoracic aortic smooth-muscle (RTASM) cells. These parameters were directly determined by measuring 125I-ANF binding to total, intracellular and cell-surface receptors. Pretreatment of cells with the lysosomotropic agent chloroquine and the energy depleter dinitrophenol led to an increase in the intracellular 125I-ANF radioactivity. After 60 min incubation at 37°C, cell-associated 1251-ANF radioactivity fell rapidly in chloroquine-treated cells (> 85 %) compared with the controls (< 45 %).1251-ANF radioactivity increased to a peak of 65 % of the initial level within 15 min in chloroquine-treated cells compared with only 22 % in the control cells. During the initial incubation period at 37°C, chloroquine inhibited the release of both intact and degraded 125I-ANF in a time-dependent manner. However, at later incubation times, the effect of chloroquine was diminished and release of both degraded and intact ligand was resumed. Extracellular unlabelled ANF did not affect the release of degraded 1251I-ANF but it accelerated the release of intact ANF by a retroendocytotic mechanism. After the endocytosis, about 30-40 % of ANF receptors were restored to the cell surface from the internalized pool of receptors. The restoration was blocked by chloroquine or dinitrophenol but not by cycloheximide. Exposure of RTASM cells to unlabelled ANF resulted in a time-and concentration-dependent loss of ANF receptors. Unlabelled ANF (10 nM) induced a loss of more than 52 % of 125I-ANF binding, and a complete loss occurred at micromolar concentrations. It is inferred that ANF-induced down-regulation of its receptor resulted primarily from an increased rate in internalization and metabolic degradation of ligand-receptor complex by receptor-mediated endocytotic mechanisms.
INTRODUCTION
Atrial natriuretic factor (ANF), a peptide hormone produced in the specific granules of atrial myocytes, plays an important role in the regulation of extracellular fluid volume and electrolyte homoeostasis (deBold et al., 1981) . ANF stimulates the renal excretion of salt and water (Flynn et al., 1983; Atlas et al., 1984; Seidah et al., 1984) and relaxation of vascular smooth-muscle cells (Currie et al., 1983; Grammer et al., 1983; Garcia et al., 1984) . It inhibits the release of aldosterone from adrenal gland (Atarashi et al., 1984; DeLean et al., 1984; Goodfriend et al., 1984) , renin from kidney (Burnett et al., 1984; Maack et al., 1984; Obana et al., 1985a) , vasopressin from anterior pituitary (Samson, 1985; Obana et al., 1985b) and progesterone in Leydig tumour (MA-10) cells (Pandey et al., 1985) . ANF stimulates the release of testosterone in Leydig cells (Bex & Carbin, 1985; Pandey et al., 1986a; Mukhopadhyay et al., 1986) , growth hormone in posterior pituitary (Harvath et al., 1986) and progesterone in ovarian granulosa cells (Pandey et al., 1987) . It is believed that the intracellular action of ANF is exerted through its binding to specific cell-surface receptors [for reviews see Inagami (1989) and Garbers (1989) ]. Multiple forms of ANF receptor subtypes have been proposed (Leitman et al., 1986; Scarborough et al., 1986; Pandey et al., 1988) . The structures of two ANF receptor subtypes, with guanylate cyclase activity (Chinkers et al., 1989; Lowe et al., 1989; Schulz et al., 1989; Chang et al., 1989; Pandey & Singh, 1990 ) and without guanylate cyclase activity (Fuller et al., 1988) , have been determined. The prevalence of distinct ANF receptor subtypes seems to be specific to different ANF target-cell types (Pandey et al., 1988; Leitman et al., 1988) . Photoaffinity-labelling and crosslinking studies have shown that smooth-muscle cells contain predominantly the non-guanylate cyclase-type of ANF receptor (Budzik et al., 1987; Schenk et al., 1987; Pandey et al., 1988) which is also referred to as ANF clearance (ANF-C) receptor (Maack et al., 1987) . Contradictory to the hypothesis of a clearance role for these receptors, however, it has been reported that ANF-C receptors seem to be involved in the formation of inositol phosphate and diacylglycerol in cultured smooth-muscle cells (Hirata et al., 1989) and also to be negatively coupled with the adenylate cyclase system, suggesting a role in the inhibition of the intracellular accumulation of cyclic AMP (Resink et al., 1988; Anand-Srivastava et al., 1990) .
Despite extensive biochemical and molecular-biological studies, the mechanism and physiological significance of ANF receptor translocation after ligand binding is not yet clear. The binding of hormones to target cells seems to be highly regulated by several mechanisms including the ligand itself. Although, after long-term exposure of cultured smooth-muscle cells to ANF a decrease in ANF receptors was previously noticed (Hirata et al., 1985b; Roubert et al., 1987; Bellerman & Neuser, 1988; Hamet et al., 1988; Cahill et al., 1990) , an interrelationship between the endocytotic mechanisms, intracellular sequestration of the ANF-receptor complex and ANF-dependent downregulation in smooth muscle cells has not been demonstrated. This present report provides an insight into the pathways involved 55 Abbreviations used: ANF, atrial natriuretic factor; RTASM, rat thoracic aortic smooth-muscle cells; DMEM, Dulbecco's modified Eagle's medium. Vol. 288 in the intracellular sequestration of ANF-receptor complex and ligand-dependent receptor down-regulation in rat thoracic aortic smooth-muscle (RTASM) cells. In these studies, the lysosomotropic agent chloroquine and the energy depleter dinitrophenol, which are known to interfere with the intracellular routing and redistribution of the ligand-receptor complex, have been utilized. Chloroquine is known to inhibit lysosomal degradation and dinitrophenol disrupts energy-dependent intracellular trafficking of the ligand-receptor complex (Carpenter & Cohen, 1976; Stein & Sussman, 1986 Beckman Gamma-4000.
Release of surface-bound 1251-ANF radioactivity by treatment with acid buffer Cells in 6 cm2 culture dishes were allowed to bind 125I-ANF at 4 "C or at 37 "C for appropriate times and the binding reaction was terminated by aspirating the medium and washing the dishes four times (2 ml each wash) with ice-cold assay medium as described above. The dishes then received 1 ml of ice-cold glycine acidic buffer (50 mM-glycine/I00 mM-NaCl, pH 3.5) and were incubated for 2 min at 4 'C. Acid eluates from the dishes were collected and another 1 ml of cold acid buffer was used to wash the dishes. The two solutions were combined and acid-sensitive radioactivity was determined. The cells were dissolved in 0.5 MNaOH which yielded acid-resistant radioactivity. The sum of the acid-sensitive and acid-resistant radioactivity was considered to be the total radioactivity.
Analysis of surface-bound, internalized and released 1251-ANF in
RTASM cells
Confluent culture dishes were washed twice (2 ml each wash) with assay medium (DMEM containing 0.1 % BSA) and 2 ml of fresh medium was added to each dish. Cells were pretreated with either chloroquine (200 #M) or dinitrophenol (1 mM) for 30-45 min at 37 "C and then allowed to bind 125I-ANF at 4 "C for 1 h, unless otherwise indicated. After completion of the binding reaction, cells were washed four times (2 ml each wash) with binding assay medium and each dish received 2 ml of fresh medium. All dishes were incubated at 37 "C to permit the internalization of bound 1251-ANF. At the indicated times, the distribution of 125I-ANF radioactivity between the cell surface, the cell interior and that released into the medium was determined. The amount of internalized 1251-ANF was quantified by stripping the surface-bound ligand by treatment with glycine acidic buffer, pH 3.5. At appropriate time intervals, cells were removed from the 37 "C incubation and placed on ice. Medium was collected and cells were treated with acid buffer at pH 3.5 for 2 min as described above. The acid eluate was collected and cells were dissolved in 0.5 M-NaOH. The surface-bound, internalized and released 1251-ANF radioactivity was counted in acid eluate, cell extract and culture medium respectively. The amount of intact and degraded ligand was determined by solubility of 1251 ANF products in trichloroacetic acid. The 1251I-ANF precipitable in 5 % trichloroacetic acid was considered to represent intact 1251-ANF molecules. Samples of the culture media were applied to a C18 reversed phase h.p.l.c. column for further analysis of the nature of 1251 radioactivity as described elsewhere (Pandey et al., 1986b) .
Down-regulation of ANF receptors in RTASM cells
The confluent culture dishes were washed twice (2 ml each wash) with DMEM containing 0.1 % BSA (assay medium) and a fresh 2 ml of medium was added to each dish. Cells were treated with various concentrations of ANF for various time periods at 37 "C. After completion of ANF treatment, cells were washed with acidic buffer, pH 3.5, to remove any remaining bound ANF. After the acid wash, cells were neutralized by thoroughly washing with assay medium (DMEM/0.1 % BSA), and then 1251-ANF binding was determined.
Ligand-dependent internalization and recycling of ANF receptors
Confluent cultures received cycloheximide for 2 h at 37 "C, after which ANF (1 /M) was added and dishes were further incubated for 1 h at 37 "C. Cells were washed free of ANF and further incubated in fresh medium with or without cycloheximide. Specific 1251-ANF binding was determined at the indicated times in both cycloheximide-treated and untreated cells. Recycling of ANF receptors in RTASM cells was also determined after treatment of the cells with trypsin. Cells were washed with assay medium and then exposed to trypsin (0.025 %) at 4 "C for 5 min. After trypsin treatment, cells were quickly washed with serumcontaining medium followed by three washes with assay medium, and then incubated in fresh medium at 37 "C for the indicated time periods to determine 1251I-ANF binding. The 
RESULTS
Release of acid-sensitive bound '25l-ANF Acid treatment rapidly released 85-90 % of bound 1251-ANF from the cell surface within 2 min. In these experiments, acid treatment effectively separated surface-bound and internalized 1251-ANF. At 4°C, almost 95 % of bound 125I-ANF was acidsensitive irrespective of the incubation time (Fig. la) . At 37°C, 66% of bound 1251-ANF was acid-sensitive during the initial incubation times and this then declined rapidly (Fig. lb) .
Internalization and sequestration of ANF-receptor complex in RTASM cells
Culture dishes with and without chloroquine were incubated at 37°C for 45 min, cooled at 4°C and cell-surface receptors were labelled with 125I-ANF for 1 h. After removal of the unbound ligand, cells were rapidly warmed to 37°C in the fresh medium. At the indicated time intervals, the radioactivity associated with the cell surface, internalized into the cell interior and released into the culture medium was quantified by utilizing the acid wash procedure which specifically dissociated surface-bound Quantitative analysis of lSSI-ANF radioactivity in RTASM cells after pretreatment with the lysomotropic agent chloroquine Confluent monolayer cells in 6 cm2 culture Petri dishes were pretreated with chloroquine for 30 min. Both (a) controls and (b) chloroquine-treated cultures were allowed to bind 125I-ANF at 4°C for 60 min, after which cells were washed with cold assay medium to remove the unbound ligand and warmed to 37 'C. At the indicated time intervals, the cell-surface (A), internalized (0) and released (Cl) radioactivity was determined in acid eluates, cell extracts and culture medium as described in the Experimental section. Each point represents the mean of three separate determinations. (Fig. 2a) . At 37°C, cell-associated radioactivity fell more rapidly in chloroquine-treated cells than in controls. After 1 h incubation, only 15 % 125I radioactivity was associated with the cell surface in chloroquine-treated cells compared with 55 % in controls (Figs. 2a and 2b) . After 15 min, in chloroquinetreated cells the acid-resistant (internalized) 1251I-ANF radioactivity accounted for 65 % compared with only 22 % in control cells. However, after 2 h incubation the effect of chloroquine was diminished and intracellular 1251-ANF radioactivity decreased rapidly. The 1251-ANF radioactivity in the culture medium increased steadily up to 4 h and then plateaued. In control cells, the internalized 1251 radioactivity was maintained at a steadystate level from 15 min to 4 h and then declined slightly (Figs. 2a and 2b). reincubated at 37°C for different time periods. One set of cultures also received unlabelled ligand (0.1 ,uM-ANF). The internalized 1251-ANF radioactivity remained at a much higher level in chloroquine-pretreated cells than in the controls (Fig. 3) . At 37°C, approx. 85-90 % ofinternalized 1251-ANF radioactivity was released into the culture medium. The nature of the radioactivity in the medium was analysed by h.p.l.c. (reversed phase C18 column) which indicated that a major proportion of the radioactivity was eluted in the pass-through fraction as degraded products and a small proportion was eluted at the position corresponding to 1251-ANF (results not shown). Initially, chloroquine inhibited the release of degraded 125I-ANF in a timedependent manner (Fig. 4a) , but, after a longer incubation time, the release of degraded radiolabelled ligand increased steadily. The release of intact ligand increased sharply after 2 h in chloroquine-treated cells (Fig. 4b) . Extracellular unlabelled ANF did not affect the release of degraded 1251-ANF, but it accelerated the release of intact ligand in chloroquine-treated cells (Figs. 4a  and 4b ). The treatment of RTASM cells with the energy depleter dinitrophenol for 30 min at 37°C also inhibited the degradation of 125I-ANF by approx. 50 % compared with untreated cells (Fig.  5) .
1251-ANF

ANF-dependent down-regulation of its receptor in RTASM cells
The exposure of RTASM cells to ANF (10 nM) caused a substantial decrease in ANF receptors leading to a loss of 50-60 % of total receptor number without changing the affinity of the binding sites (results not shown). RTASM cells were pretreated with various concentrations of unlabelled ANF for increasing time periods as shown in Fig. 6 . ANF (at 10 nM) markedly decreased the surface binding in 45 min and the micromolar concentration of ANF produced almost a complete loss of cell surface binding (Fig. 6 ).
Internalization and recycling of ANF receptors in RTASM ceUs
In order to determine if the internalized ANF receptors are washed with assay medium to remove the unbound ligand, one group of chloroquine-treated cells was exposed to unlabelled ANF (10 nM) (O, *). All cultures were incubated at 37 'C and media were collected. Samples of medium from triplicate dishes were precipitated with trichloroacetic acid and both (a) degraded and (b) intact 125I-ANF were quantified as outlined in the Experimental section. Data represent means + S.E.M. of three separate determinations.
returned to the cell surface, RTASM cells were incubated with ANF (0.1 zM) for 1 h which produced an almost complete loss of specific cell-surface binding of 125I-ANF. After pretreatment with unlabelled ANF, cells were washed with acid buffer to remove any bound ANF and incubated at 37°C in fresh medium which exhibited a gradual return to cell-surface 1251-ANF binding (Li = 20 min). In 40 min the surface binding returned to approx. 35 % of the original level (Fig. 7) . A parallel set of culture dishes was also incubated in the presence of cycloheximide (a proteinsynthesis inhibitor) at 37°C for 2 h preceding the ANF pretreatment and during the remainder of the incubation. The cycloheximide-pretreated cells also exhibited a return to cellsurface 125I-ANF binding. In another experiment, RTASM cells were treated with a low concentration of trypsin (0.025 %) at 4°C for 5 min which abolished cell-surface 1251-ANF binding. After the cells were washed free of trypsin with serum containing DMEM and incubated in fresh assay medium at 37°C, a return to cell-surface 125I-ANF binding was observed in both cycloheximide-treated and untreated cells (Fig. 8) . 
DISCUSSION
This present study was undertaken to investigate the processes involved in the endocytotic uptake, intracellular processing and ANF-dependent down-regulation of its receptors in a model RTASM. cell-system. Altahough the internalization of ANF receptors in vascular smooth-muscle cells has been previously documented (Hirata et al., 1985a; Napier et al., 1986; Nussenzveig et al., 1990) (Rathinavelu & Isom, 1991 A major proportion of internalized 125I-ANF was released into the culture medium which consisted of both degraded products and intact 125I-ANF. It was found that approx. 80-85% of the released 1251 radioactivity constituted the degraded products and about 15-20% was intact ligand. These observations suggest that the majority of internalized 125I-ANF is processed through the degradative compartments. Nevertheless, an alternative mechanism also seems to exist for the release of intact ligand in RTASM cells. Although the release of degraded ligand was blocked to a great extent by the lysosomotropic agent chloroquine, this agent was only partially effective in blocking the release of intact 125I-ANF. The treatment of cells with unlabelled ANF further diminished the effect of chloroquine on the release of intact ligand, but it did not modify the effect of chloroquine in blocking the release of degraded products. Dual pathways for intracellular processing of peptide hormones have previously been described (Anderson et al., 1977; Tietze et al., 1982) , suggesting the release of intact ligand through retroendocytosis and release of degraded products through simple diffusion into the culture medium (Marshall, 1985) . It is also conceivable that retroendocytosis ofa certain ligand could be the result ofrecycling of the receptor-ligand complex leading to the dissociation of the ligand from the receptor at the plasma membrane.
In these present studies the short-term exposure of RTASM cells with increasing concentrations of unlabelled ANF resulted in a loss of cell-surface receptors (Fig. 6) . The maximal effect of ANF on down-regulation of its receptor occurred between 30 and 60 min, suggesting the involvement of receptor-mediated endocytosis and subsequent metabolic degradation and redistribution of the ANF-receptor complex. Approx. 30 % of ANF receptors returned to the cell surface in ANF-treated cells. Unlabelled ANF accelerated the release of intact ligand, indicating that ANF-dependent down-regulation of its receptor involves the internalization of the ligand-receptor complex which dissociates intracellularly and escapes the lysosomal degradative pathway. In addition to the ligand-dependent down-regulation of ANF receptors in vascular smooth-muscle cells, it has been shown that cyclic GMP also down-regulates ANF receptors in cultured vascular endothelial cells (Kato et al., 1991) . However, further studies are needed to support the notion that cyclic GMP is indeed involved in the down-regulation of ANF receptors in other tissues and cell systems.
The data presented here show that a proportion of internalized ANF receptors in RTASM cells recycle back to the plasma membranes. As a result, only 50 % of surface receptors were lost in control cells at 37°C after 8 h incubation, compared with an 85-90% receptor loss in chloroquine-pretreated cells (Figs. 2a and 2b) . Since ANF at a concentration of 1 ,/M induced an almost complete loss of cell-surface binding at 37°C, this strategy was utilized to examine the recycling of ANF receptors in these cells. After ANF treatment, cells were washed with acid buffer to remove any bound ligand and then incubated in the fresh assay medium at 37°C; a gradual return to surface binding occurred (t, = 20 min). A return of 1251I-ANF binding was also observed in cycloheximide-treated cells. These observations provided the evidence that the internalized ANF receptors in RTASM cells recycled back to the plasma membrane. In a parallel experiment, RTASM cells were treated with trypsin at 4°C for 5 min, which abolished cell-surface 1251I-ANF binding. After the cells had been washed free of trypsin and incubated in fresh medium at 37°C, a return to 1251-ANF binding was observed. However, in cycloheximide-treated cells, binding of 1251-ANF was 30-40 % lower than in control cells. These findings further strengthened the view that a return to ANF binding in RTASM cells was due to recycling of the receptor molecules. Since a complete return to ANF binding did not occur, protein synthesis de novo may also be involved.
In conclusion, the present studies show that ANF receptors in RTASM cells are internalized and redistributed in the cell interior which provides an approach to the direct examination of the dynamics of ANF-receptor complex sequestration and processing in RTASM cells. The translocation of the ANF-receptor complex from the cell surface to the intracellular compartments seems to be linked to ANF-dependent receptor down-regulation. The ability of ANF to substantially decrease the level of ANF receptors in RTASM cells is linked to the internalization and accumulation of the ANF-receptor complex in the cell interior. Most of the internalized 1251-ANF in RTASM cells is processed through the lysosomal degradative pathways, but an alternative mechanism also seems to exist for the release of intact ligand by retroendocytosis.
